Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.

MENU

Primary tabs

Fox Chase Cancer Center News

Primary tabs

Jonathan Soboloff, PhD
September 27, 2022

Melanoma Cells Metastasize When Key Calcium Entry Pathway is Suppressed, Study Shows

PHILADELPHIA (September 27, 2022)—Researchers at Fox Chase Cancer Center have identified a new cellular pathway that plays a key role in causing melanoma to become invasive and hastening its spread.

Bojana Gligorijevic, PhD
September 27, 2022

Fox Chase, Temple University Researchers Develop Further Insight Into How Cells Metastasize in Breast Cancer

PHILADELPHIA (September 27, 2022)—In a recently published study, researchers at Fox Chase Cancer Center and Temple University found that only a few so called “leader cells” are necessary for metastasis of breast cancer—the spread of cancer cells from their point of origin to other parts of the body—to occur. The finding underscores the need for more personalized and targeted approaches to fighting cancer.

Michael Hall, MD, MS, Chair, Department of Clinical Genetics
September 16, 2022

Cancer Screening Gaps Highlight Urgent Need to Address Health Inequities, According to NCCN Policy Summit

PHILADELPHIA (September 16, 2022)— The National Comprehensive Cancer Network® (NCCN®) hosted a policy summit to examine practice changes and trends in legislative and regulatory efforts that affect patient access to cancer screening and risk reduction.

Camille Ragin, PhD, MPH, a professor in the Cancer Prevention and Control research program
September 15, 2022

Fox Chase Receives Grant to Study Prostate Cancer Patients Being Treated With Androgen Deprivation Therapy

PHILADELPHIA (September 15, 2022)—Researchers at Fox Chase Cancer Center have been awarded a three-year $250,000 grant to investigate methods of improving the cardiovascular management of patients with prostate cancer being treated with androgen deprivation therapy (ADT).

Igor Astsaturov, MD, PhD, a co-director of the institute and an associate professor in the Department of Hematology/Oncology
September 15, 2022

Study Finds New Synthetic Lethal Agent Could Be Potential Treatment for Pancreatic Cancer

PHILADELPHIA (September 15, 2022)—Researchers at The Marvin and Concetta Greenberg Pancreatic Cancer Institute at Fox Chase Cancer Center have found that a new synthetic lethal agent could be an effective treatment for pancreatic cancers with DNA damage repair (DDR) defects.

Marcin Chwistek, MD, FAAHPM, a professor in the Department of Hematology/Oncology and director of the SOPCP
September 15, 2022

Fox Chase Cancer Center Earns Recertification for Palliative Care Program

PHILADELPHIA (September 15, 2022)—The Supportive Oncology and Palliative Care Program (SOPCP) at Fox Chase Cancer Center has earned Joint Commission Advanced Palliative Care Certification, marking the fourth consecutive time the program has achieved this distinction.

Jaye Gardiner, PhD, a postdoctoral fellow at Fox Chase Cancer Center
September 14, 2022

Fox Chase Cancer Center’s Jaye Gardiner Receives Award for Outstanding Postdoc From the American Society for Cell Biology

PHILADELPHIA (September 14, 2022)—Jaye Gardiner, PhD, a postdoctoral fellow at Fox Chase Cancer Center, was recently awarded the Merton Bernfield Memorial Award from the American Society for Cell Biology (ASCB), making her one of 18 scientists from across the country to be recognized for their achievements in the life sciences.

Anthony M. Villano, MD, as a clinical instructor in the Department of Surgical Oncology
September 13, 2022

Fox Chase Cancer Center Welcomes Dr. Anthony M. Villano

PHILADELPHIA (September 13, 2022)—Fox Chase Cancer Center is pleased to announce the hiring of Anthony M. Villano, MD, as a clinical instructor in the Department of Surgical Oncology.

Pages

Connect with Fox Chase